Federal multidistrict litigation tracker

MDL 3092 Update — Suboxone Tooth Decay Lawsuit

In re: Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation. Counts are monthly JPML snapshots and can change between reports.

Lawsuit status — September 2026

Suboxone Tooth Decay Lawsuit

Verified September 14, 2026

MDL: MDL-3092
Court: N.D. Ohio
Judge: Judge J. Philip Calabrese
Pending cases: 1,827; 0 since prior report
Current phase: Core discovery and provider depositions
Settlement status: No public settlement program identified
Latest development: JPML reports 1,827 pending actions on September 1, 2026, compared with 1,827 on August 3; 1,908 total historical actions are reported separately.
Next major event: January 15, 2027 — Core discovery deposition period ends

What changed this month?

●JPML reports 1,827 pending actions on September 1, 2026, compared with 1,827 on August 3; 1,908 total historical actions are reported separately. Source
●CMO 23, entered July 16, governs provider depositions in the core discovery pool. Source
●The bellwether protocol schedules core-pool depositions through January 15, 2027 and selection of 15 trial-pool cases on January 29, 2027. Source
●March 2028 appears in the protocol as a proposed first trial setting, not an entered trial date. Source

MDL details

Created: February 2, 2024
Pending: 1,827
Total actions filed: 1,908
Monthly change: 0

Defendants named in the tracked record

Indivior Inc.; Indivior Solutions Inc.; Aquestive Therapeutics Inc.. Defendants dispute the allegations.

Historical case counts

Report	Pending	Total filed
September 1, 2026	1,827	1,908
August 3, 2026	1,827	1,908
July 1, 2026	1,832	—

What the litigation alleges

The tracked claims concern prescription drug dental injury claim, including severe dental injuries. These are allegations; defendants dispute liability and causation.

Stage and bellwether status

The July 16, 2026 CMO 23 governs provider depositions in the core discovery pool. The Second Amended CMO 15 schedules core-pool depositions through January 15, 2027 and trial-pool selection for January 29. Its later timetable describes March 2028 as a proposed first trial setting, not a fixed trial date.

Bellwether record: Protocol schedules selection of 15 trial-pool cases.

Settlement status

The Northern District of Ohio public MDL order index and bellwether protocol reviewed September 14, 2026 do not announce a dental-injury settlement program or individual payout schedule. Separate Suboxone antitrust and opioid-enforcement settlements do not resolve these dental-injury claims.

Individual claims: The Northern District of Ohio public MDL order index and bellwether protocol reviewed September 14, 2026 do not announce a dental-injury settlement program or individual payout schedule. Separate Suboxone antitrust and opioid-enforcement settlements do not resolve these dental-injury claims.